Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Feb;19(2):1091-1094.
doi: 10.3892/etm.2019.8311. Epub 2019 Dec 10.

Successful treatment of a 12-year-old boy with Guillain-Barré syndrome requiring tracheostomy due to respiratory muscle paralysis: A case report

Affiliations

Successful treatment of a 12-year-old boy with Guillain-Barré syndrome requiring tracheostomy due to respiratory muscle paralysis: A case report

Manabu Miyamoto et al. Exp Ther Med. 2020 Feb.

Abstract

Childhood Guillain-Barré syndrome (GBS) occasionally leads to respiratory failure early after onset, requiring long-term ventilation management after tracheal intubation. However, patients requiring tracheostomy management are rare. In the present study, a case of a 12-year-old boy with GBS who required artificial respiration management due to rapid progression of respiratory muscle paralysis is reported. Intravenous immunoglobulin (IVIg) and pulse steroid therapy were provided; however, both were ineffective and tracheostomy was necessary 26 days after onset. A second course of IVIg and pulse steroid therapy was administered on day 34. With continued rehabilitation, the patient was able to walk long distances on day 74 and was subsequently discharged on day 89. In cases of severe GBS, when IVIg and pulse steroid therapy do not improve the respiratory muscle strength of the patient, early tracheostomy may improve the patient's quality of life during artificial respiration management.

Keywords: Guillain-Barré syndrome; children; immunoglobulin; steroid pulse; tracheostomy.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Clinical course of patient with GBS. GBS, Guillain-Barré syndrome; MMT, manual muscle testing; IVIg, intravenous immunoglobulin; mPSL, methylpredonisolone pulse.

Similar articles

References

    1. van den Berg B, Walgaard C, Drenthen J, Fokke C, Jacobs BC, van Doorn PA. Guillain-Barré syndrome: Pathogenesis, diagnosis, treatment and prognosis. Nat Rev Neurol. 2014;10:469–482. doi: 10.1038/nrneurol.2014.121. - DOI - PubMed
    1. Hughes RA, Cornblath DR. Guillain-Barré syndrome. Lancet. 2005;366:1653–1666. doi: 10.1016/S0140-6736(05)67665-9. - DOI - PubMed
    1. Yuki N, Hartung HP. Guillain-Barré syndrome. N Engl J Med. 2012;366:2294–2304. doi: 10.1056/NEJMra1114525. - DOI - PubMed
    1. Walgaard C, Jacobs BC, Lingsma HF, Steyerberg EW, Cornblath DR, van Doorn PA, van Doorn PA, Jacobs BC, Walgaard C, de Wit MC, et al. Dutch GBS Study Group Second IVIg course in Guillain-Barré syndrome patients with poor prognosis (SID-GBS trial): Protocol for a double-blind randomized, placebo-controlled clinical trial. J Peripher Nerv Syst. 2018;23:210–215. doi: 10.1111/jns.12286. - DOI - PubMed
    1. Yoshida M, Ikeda J, Urikane Y, Kashiwada T, Kaseda Y, Kohriyama T. Prevalence of tracheotomy and percutaneous endoscopic gastrostomy in patients with Guillain-Barré syndrome. Dysphagia. 2017;32:236–240. doi: 10.1007/s00455-016-9750-6. - DOI - PubMed